4 Dec 2013 16:20

4 December 2013
Â
Microgen plc (the "Company")
Â
Notifiable Interests
Â
The Company received the following notice on 3 December 2013 in compliance with the Disclosure and Transparency Rules from Standard Life Investments Ltd:
Â
TR-1: Notifications of Major Interests in Shares | |||||||||||
 | |||||||||||
Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Microgen PLC Â | ||||||||||
Reason for notification (yes/no) | |||||||||||
An acquisition or disposal of voting rights | no | ||||||||||
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | no | ||||||||||
An event changing the breakdown of voting rights | yes | ||||||||||
Other (please specify): | Â | no | |||||||||
 |  | ||||||||||
Full name of person(s) subject to notification obligation: | Standard Life Investments Ltd | ||||||||||
Full name of shareholder(s) (if different from 3): | Vidacos Nominees | ||||||||||
Date of transaction (and date on which the threshold is crossed or reached if different): | 02/12/2013 | ||||||||||
Date on which issuer notified: | 03/12/2013 | ||||||||||
Threshold(s) that is/are crossed or reached: | 5% | ||||||||||
Notified Details | |||||||||||
Voting rights attached to shares | |||||||||||
Class/type of share If possible use ISIN code | GB0005869531 Â | ||||||||||
 | |||||||||||
Situation previous to the triggering transaction | |||||||||||
Number of shares | Number of voting rights | ||||||||||
4,120,841 Â | 4,120,841 Â | ||||||||||
 | |||||||||||
Resulting situation after the triggering transaction | |||||||||||
Number of shares | Number of voting rights | Percentage ofvoting rights | |||||||||
Direct | Indirect | Direct | Indirect | ||||||||
4,120,841 Â | 4,120,841 Â | 0 Â | 5.531 Â | 0 Â | |||||||
 | |||||||||||
Financial Instruments | |||||||||||
Resulting situation after the triggering transaction | |||||||||||
Type of financial instrument | Expiration date | Exercise/ conversion period/date | No. of voting rights that may be acquired(if the instrument exercised/converted) | Percentage of voting rights | |||||||
 |  |  |  |  | |||||||
 | |||||||||||
Total (A+B) | |||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||
4,120,841 Â | 5.531% Â Â | ||||||||||
Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: | |||||||||||
Standard Life Investments Ltd | |||||||||||
 | |||||||||||
Proxy Voting: | |||||||||||
Name of proxy holder: | Â | ||||||||||
Number of voting rights proxy holder will cease to hold: | Â | ||||||||||
Date on which proxy holder will cease to hold voting rights: | Â | ||||||||||
 | |||||||||||
Additional information: | Â | ||||||||||
Contact name: | investments_mo@standardlife.comStandard Life Investments Ltd | ||||||||||
Contact telephone number: | (0131) 245 6565 | ||||||||||
Â
Â
If you require further information please contact:
Anjum O'Neill, Company Secretary, Microgen plc Tel: 020 7496 8100
www.microgen.com
Â
Â
Â